Treatment of irritable bowel syndrome.
Farthing
Michael J G
MJ
D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D043183:Irritable Bowel Syndrome / Q000188:drug therapy*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*
D007211:Indoles; D017366:Serotonin Receptor Agonists; C105050:tegaserod
Arch Intern Med. 2001 Jul 23;161(14):1733-40
11485506
Gastroenterology. 2002 Jun;122(7):2032-48
12055608
Gastroenterology. 2003 Jul;125(1):19-31
12851867
Aliment Pharmacol Ther. 2003 Sep 15;18(6):569-80
12969083
Cochrane Database Syst Rev. 2004;(1):CD003960
14974049
Aliment Pharmacol Ther. 2004 Apr 1;19(7):729-38
15043513
Clin Gastroenterol Hepatol. 2004 Jul;2(7):576-84
15224282
Clin Gastroenterol Hepatol. 2004 Jul;2(7):585-96
15224283
Best Pract Res Clin Gastroenterol. 2004 Aug;18(4):773-86
15324713
Aliment Pharmacol Ther. 2004 Sep 15;20(6):697-8; author reply 698-9
15352919
N Engl J Med. 2004 Sep 23;351(13):1361-4; discussion 1361-4
15385670